Epidermal growth factor receptor (EGFR) signalling is activated by ligand-induced receptor dimerization. Notably, ligand binding also induces EGFR oligomerization, but the structures and functions of the oligomers are poorly understood. Here, we use fluorophore localization imaging with photobleaching to probe the structure of EGFR oligomers. We find that at physiological epidermal growth factor (EGF) concentrations, EGFR assembles into oligomers, as indicated by pairwise distances of receptor-bound fluorophore-conjugated EGF ligands. The pairwise ligand distances correspond well with the predictions of our structural model of the oligomers constructed from molecular dynamics simulations. The model suggests that oligomerization is mediated extracellularly by unoccupied ligand-binding sites and that oligomerization organizes kinase-active dimers in ways optimal for auto-phosphorylation in trans between neighbouring dimers. We argue that ligand-induced oligomerization is essential to the regulation of EGFR signalling.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095584 | PMC |
| http://dx.doi.org/10.1038/ncomms13307 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
4-Anilinoquinazoline Derivatives as the First Potent NOD1-RIPK2 Signaling Pathway Inhibitors at the Nanomolar Range.
J Med Chem
November 2024
Univ. Lille, Inserm, CHU Lille, U1286─INFINITE─Institute for Translational Research in Inflammation, Lille F-59000, France.
Inflammation is a defense mechanism that restores tissue damage and eliminates pathogens. Among the pattern recognition receptors that recognize danger or pathogenic signals, nucleotide oligomerization domains 1 and 2 (NOD1/2) have been identified to play an important role in innate immunity responses, and inhibition of NOD1 could be interesting to treat severe infections and inflammatory diseases. In this work, we identified the first selective NOD1 versus NOD2 pathway inhibitors at the nanomolar range based on a 4-anilinoquinazoline scaffold.
View Article and Find Full Text PDFNLRP3 inflammasome activation and macrophage distribution in kidney tissues from patients with acute oxalate nephropathy.
Kidney Res Clin Pract
September 2024
Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Article Synopsis
- The study examined the activation of the NLRP3 inflammasome pathway and macrophage distribution in patients with acute oxalate nephropathy (AON) compared to acute tubulointerstitial nephritis (ATIN).
- In AON patients, significant increases in inflammation and NLRP3-related markers were observed, along with a notable presence of oxalate deposits and more severe tissue damage compared to ATIN patients.
- A lower ratio of M1 to M2 macrophages was linked to worse kidney function and chronic lesions, suggesting the need for further research on these macrophage dynamics in kidney injury.
The scaffolding protein IQGAP1 enhances EGFR signaling by promoting oligomerization and preventing degradation.
J Biol Chem
November 2024
Department of Chemistry and Biochemistry, Worcester Polytechnic Institute, Worcester, Massachusetts, USA. Electronic address:
IQGAP1 is a large, multi-domain scaffold that connects and modulates different signaling networks including the one initiated by epidermal growth factor (EGF). In this study, we have used live cell fluorescence imaging methods along with other biochemical techniques to follow the mechanisms used by IQGAP1 to enhance EGF signaling. We show that IQGAP1 enhances EGF signaling by promoting the oligomerization of its receptor, EGFR, upon EGF addition along with concurrent IQGAP oligomerization.
View Article and Find Full Text PDFHER4 is a high-affinity dimerization partner for all EGFR/HER/ErbB family proteins.
Protein Sci
October 2024
Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas, USA.
Article Synopsis
- Human epidermal growth factor receptors (HER), including HER4, are important proteins that influence cell growth and survival, but HER4 is less studied due to its low expression in later development stages.
- Recent research indicates that HER4 may contribute to cancer metastasis by affecting cell movement, but its exact function in tumor development is still unclear.
- Using a technique called pulsed interleaved excitation fluorescence cross-correlation spectroscopy (PIE-FCCS), the study found that HER4 interacts with all HER receptors in live cells and this interaction increases in the presence of a specific ligand, making HER4 a key partner for dimerization among the HER proteins.
Disrupting EGFR-HER2 Transactivation by Pertuzumab in HER2-Positive Cancer: Quantitative Analysis Reveals EGFR Signal Input as Potential Predictor of Therapeutic Outcome.
Int J Mol Sci
May 2024
Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Pertuzumab (Perjeta), a humanized antibody binding to the dimerization arm of HER2 (Human epidermal growth factor receptor-2), has failed as a monotherapy agent in HER2 overexpressing malignancies. Since the molecular interaction of HER2 with ligand-bound EGFR (epidermal growth factor receptor) has been implied in mitogenic signaling and malignant proliferation, we hypothesized that this interaction, rather than HER2 expression and oligomerization alone, could be a potential molecular target and predictor of the efficacy of pertuzumab treatment. Therefore, we investigated static and dynamic interactions between HER2 and EGFR molecules upon EGF stimulus in the presence and absence of pertuzumab in HER2+ EGFR+ SK-BR-3 breast tumor cells using Förster resonance energy transfer (FRET) microscopy and fluorescence correlation and cross-correlation spectroscopy (FCS/FCCS).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!